Pharmacological c-Jun NH2-Terminal Kinase (JNK) Pathway Inhibition Reduces Severity of Spinal Muscular Atrophy Disease in Mice

Overview of attention for article published in Frontiers in Molecular Neuroscience, September 2018

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (80th percentile)
Good Attention Score compared to outputs of the same age and source (77th percentile)

Mentioned by

news: 1 news outlet

twitter: 3 X users

Citations

dimensions_citation: 26 Dimensions

Readers on

mendeley: 37 Mendeley

Summary News X Dimensions citations

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 74,571 followers.

RT @FrontNeurosci: Pharmacological c-Jun NH2-Terminal Kinase (JNK) Pathway Inhibition Reduces Severity of Spinal Muscular Atrophy Disease i…

16 Sep 2018

Reply Repost Favourite

RT @FrontNeurosci: Pharmacological c-Jun NH2-Terminal Kinase (JNK) Pathway Inhibition Reduces Severity of Spinal Muscular Atrophy Disease i…

15 Sep 2018

Reply Repost Favourite

Pharmacological c-Jun NH2-Terminal Kinase (JNK) Pathway Inhibition Reduces Severity of Spinal Muscular Atrophy Disease in Mice: Roberta Schellino, Marina Boido, Tiziana Borsello, Alessandro Vercelli https://t.co/ZMvUeU5Q4o

15 Sep 2018

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.